AQR Arbitrage’s Celularity Inc CELUW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-71,695
Closed -$98K 1507
2022
Q1
$98K Sell
71,695
-44,194
-38% -$36K ﹤0.01% 788
2021
Q4
$593K Sell
115,889
-2,080
-2% -$2.11K 0.02% 836
2021
Q3
$136K Sell
117,969
-420,867
-78% -$563K ﹤0.01% 773
2021
Q2
$727K Sell
538,836
-116,698
-18% -$140K 0.02% 543
2021
Q1
$721K Sell
655,534
-244,466
-27% -$381K 0.03% 468
2020
Q4
$2.59M Sell
900,000
-100,000
-10% -$187K 0.09% 223
2020
Q3
$1.6M Hold
1,000,000
0.06% 247
2020
Q2
$1.14M Hold
1,000,000
0.05% 267
2020
Q1
$580K Hold
1,000,000
0.02% 322
2019
Q4
$800K Hold
1,000,000
0.01% 317
2019
Q3
$600K Buy
+1,000,000
New +$572K 0.01% 320

Other funds holding CELUW

AQR Arbitrage's CELUW Position: Q2 2022 in Review

AQR Arbitrage sold out of Celularity Inc (CELUW) in Q2 2022, closing a stake of 71,695 shares — an estimated $98K sold.

AQR Arbitrage first reported a position in CELUW in Q3 2019 and held it in 11 quarters. The position peaked at $2.59M in Q4 2020. 22 funds tracked by Wall St. Rank hold CELUW as of Q2 2022.

  • AQR Arbitrage reported no remaining Celularity Inc position as of Q2 2022 after selling out during the quarter.
  • AQR Arbitrage sold 71,695 Celularity Inc shares in Q2 2022, an estimated $98K.
  • AQR Arbitrage first reported a position in Celularity Inc in Q3 2019 and held it in 11 quarters.
  • AQR Arbitrage's Celularity Inc position peaked at $2.59M in Q4 2020.
  • 22 funds tracked by Wall St. Rank held Celularity Inc as of Q2 2022.

Based on AQR Arbitrage's 13F filing for Q2 2022, filed 15 Aug 2022.